Open AccessPreliminary study on the function of the POLD1 ( CDC2 ) EXON2 c.56G>A mutation
Author(s) -
Liu Jing,
Liu Yu,
Fu Jingxuan,
Liu Chengeng,
Yang Tingting,
Zhang Xiaomin,
Cao Min,
Wang Peichang
Publication year - 2020
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.1280
Subject(s) - biology , dna polymerase , missense mutation , mutation , dna damage , microbiology and biotechnology , genetics , cancer research , dna , gene
Background Fanconi anemia (FA) is a rare recessive disease characterized by DNA damage repair deficiency, and DNA polymerase δ (whose catalytic subunit is encoded by POLD1 , also known as CDC2 ) is closely related to DNA damage repair. Our previous study identified a novel POLD1 missense mutation c.56G>A (p. Arg19>His) in FA family members. However, the function of the POLD1 missense mutation is currently unknown. This study aimed to uncover the biological function of the POLD1 missense mutation. Methods Stable cell lines overexpressing wild‐type POLD1 or mutant POLD1 (c.56G>A, p.Arg19His) were constructed by lentivirus infection. Cell growth curve analysis, cell cycle analysis, and a comet assay were used to analyze the function of the POLD1 mutation. Results The growth and proliferative ability of the cells with POLD1 mutation was decreased significantly compared with those of the wild‐type cells (Student's t test, p < .05). The percentage of cells in the G0/G1 phase increased, and the percentage of cells in the S phase decreased significantly when POLD1 was mutated (Student's t test, p < .05). Moreover, the Olive tail moment value of the cells with the POLD1 mutation was significantly higher than that of the cells with wild‐type POLD1 after H 2 O 2 treatment. Conclusions The POLD1 mutation inhibited cell proliferation, slowed cell cycle progression, and reduced DNA damage repair.